This inventor holds 1 USPTO granted patent. Top assignee: Alx Oncology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jaume Pons: Innovator in Cancer Treatment
Introduction
Jaume Pons is a notable inventor recognized for his contributions to the field of cancer treatment. His innovative work focuses on developing therapies that target specific interactions within cancer cells. With a commitment to advancing medical science, Pons has made significant strides in his research.
Latest Patents
Jaume Pons holds a patent for a groundbreaking invention titled "Combination Therapies Comprising an Agent that Blocks the Interaction Between CD47 and SIRPa for Treating Gastric or Gastroesophageal Junction Cancer." This patent represents a significant advancement in the treatment of gastric cancers, showcasing Pons' dedication to improving patient outcomes.
Career Highlights
Pons is currently associated with Alx Oncology Inc., where he continues to work on innovative cancer therapies. His role at the company allows him to collaborate with other experts in the field, further enhancing the potential impact of his research.
Conclusion
Jaume Pons is a distinguished inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His patent and ongoing research contribute to the fight against cancer, offering hope for improved therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile